Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma

Eric Deconinck, Houda Miadi-Fargier, Claude Le Pen, Pauline Brice

Open source

DOI: 10.2165/11314070-000000000-00000
Published: 2010-01
Container: PharmacoEconomics
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2165/11314070-000000000-00000,
  title = {Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma},
  author = {Eric Deconinck and Houda Miadi-Fargier and Claude Le Pen and Pauline Brice},
  year = {2010},
  journal = {PharmacoEconomics},
  doi = {10.2165/11314070-000000000-00000},
  url = {https://doi.org/10.2165/11314070-000000000-00000}
}

RIS

TY  - JOUR
TI  - Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma
AU  - Eric Deconinck
AU  - Houda Miadi-Fargier
AU  - Claude Le Pen
AU  - Pauline Brice
PY  - 2010
JO  - PharmacoEconomics
DO  - 10.2165/11314070-000000000-00000
UR  - https://doi.org/10.2165/11314070-000000000-00000
ER  -

APA

Deconinck, E., Miadi-Fargier, H., Pen, C. L., & Brice, P. (2010). Cost Effectiveness of Rituximab Maintenance Therapy in Follicular Lymphoma. PharmacoEconomics. https://doi.org/10.2165/11314070-000000000-00000

Source records

crossref · retrieved 2026-09-26T01:21:13.504Z